Skip to main content
. 2022 Feb 10;7(2):e008315. doi: 10.1136/bmjgh-2021-008315

Table 2.

African countries that have approved COVID-19 vaccination for children and adolescents*

Vaccine type Vaccine name Manufacturer and country WHO emergency use listing?*21 Country Approval date for paediatric use Paediatric age indication (years)
1 messenger RNA (mRNA) BNT162b2 Pfizer-BioNTech (USA/Germany) Yes Uganda
Mauritius
Morocco
Seychelles
South Africa
Guinea Conakry
Namibia
Ghana
Egypt
Egypt
Nigeria
26 July 202136
August 202137
31 August 202137
9 September 202138
10 September 202139
10 November 202138
12 November 202140
16 November 202141
2 November 202142
28 November 202143
14 January 202244
12–17
12–17
12–17
12–17
12–17
12–17
12–17
15–17
15–18
12–15
16–17
2 mRNA-1273 Moderna (USA) Yes Guinea Conakry
Nigeria
10 November 202138
14 January 202244
12–17
16–17
3 Viral vector Ad26.COV2.S Johnson & Johnson/Janssen (USA/Belgium) Yes Nigeria 14 January 202244 16–17
4 AZD1222 Oxford-AstraZeneca (UK) Yes Nigeria 14 January 202244 16–17
5 Covishield Serum Institute of India Yes Nigeria 14 January 202244 16–17
6 Sputnik Light Gamaleya (Russia) No None
7 Sputnik V Gamaleya (Russia) No Nigeria 14 January 202244 16–17
8 Inactivated virus BBIBP-CorV Sinopharm (China) Yes Morocco
Nigeria
31 August 202137
14 January 202244
12–17
16–17
9 CoronaVac Sinovac (China) Yes Zimbabwe 1 November 202145 16–17
10 Covaxin Bharat Biotech (India) Yes None
11 Protein based Corbevax Biological-E (India) No None
12 Covovax Serum Institute of India (India) Yes None
13 NVX-CoV2373 Novavax (USA) Yes None
14 DNA ZyCoV-D Zydus Cadila (India) No None

*As of 14 January 2022.

†Waiver granted for 16 and 17 year-olds to get any available COVID-19 vaccine if needed for educational (e.g school vaccine mandate, international institution admission/attendance requirements) and international travel purposes. Approvals in table indicated for vaccines currently available in Nigeria.4